Tissue sampling in lung cancer: a review in light of the MERIT experience.
Lung cancer (Amsterdam, Netherlands).
Times cited: 20
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology.
Times cited: 25